Open Actively Recruiting

Patient Sample Collection for a Next-Generation, Off-The-Shelf CAR-iNKT Cell Therapy for Multiple Myeloma and collection of cell lines (HEK239T, HT-29, MM.1S from ATCC) and human Cord Blood (CD 34+ HSCs from HemaCare) from commercial sources

About

Brief Summary

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

Phase
N/A

Eligibility

Minimum Age
N/A
Maximum Age
N/A

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
21-001444
Category
Multiple Myeloma
Contact
Vladimir Kustanovich